# Rasmus Ehren

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rasmus-ehren/

## Facts

| Field | Value |
| --- | --- |
| Citations | 635 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 15 |
| i10-index | 17 |
| Last Known Institution | University of Cologne |
| OpenAlex ID | https://openalex.org/A5027620181 |
| ORCID iD | 0000-0002-3245-7481 |
| Works | 52 |

## Researcher papers

- [A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome](https://scholariq.org/papers/a-multicenter-randomized-placebo-controlled-double-blind-phase-3-trial-with-open/)
- [Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome](https://scholariq.org/papers/mycophenolate-mofetil-therapy-in-children-with-idiopathic-nephrotic-syndrome/)
- [The role of the immune system in idiopathic nephrotic syndrome](https://scholariq.org/papers/the-role-of-the-immune-system-in-idiopathic-nephrotic-syndrome/)
- [A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants](https://scholariq.org/papers/a-multicenter-retrospective-study-of-calcineurin-inhibitors-in-nephrotic/)
- [Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy —short version of the updated German best practice guideline (S2e) — AWMF register no. 166-001, 6/2020](https://scholariq.org/papers/pediatric-idiopathic-steroid-sensitive-nephrotic-syndrome-diagnosis-and-therapy/)
- [Mycophenolate mofetil following glucocorticoid treatment in Henoch-Schönlein purpura nephritis: the role of early initiation and therapeutic drug monitoring](https://scholariq.org/papers/mycophenolate-mofetil-following-glucocorticoid-treatment-in-henoch-schonlein/)
- [Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid‐resistant nephrotic syndrome](https://scholariq.org/papers/clinical-practice-recommendations-for-recurrence-of-focal-and-segmental/)
- [Peritoneal dialysis in extremely and very low-birth-weight infants](https://scholariq.org/papers/peritoneal-dialysis-in-extremely-and-very-low-birth-weight-infants/)
- [Extrarenal Manifestations in Shigatoxin-associated Haemolytic Uremic Syndrome](https://scholariq.org/papers/extrarenal-manifestations-in-shigatoxin-associated-haemolytic-uremic-syndrome/)
- [Therapeutic drug monitoring of mycophenolate mofetil in pediatric patients: novel techniques and current opinion](https://scholariq.org/papers/therapeutic-drug-monitoring-of-mycophenolate-mofetil-in-pediatric-patients-novel/)
- [Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS](https://scholariq.org/papers/repetitive-administration-of-rituximab-can-achieve-and-maintain-clinical/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

## Researcher university

- [University of Cologne](https://scholariq.org/institutions/university-of-cologne/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.